Hepatitis
B Top News Articles
|
| |
|
|
Adding
Adefovir Works Better
than Entecavir Monotherapy
for Lamivudine-resistant Hepatitis B Patients
8-27-2010
|
Meta-analysis
Finds Tenofovir and Entecavir
Are Most Effective Antiviral Drugs for Chronic Hepatitis
B
8-24-2010
|
HBV
DNA Decline at 24 Weeks Predicts Sustained Response to
Pegylated Interferon
for Chronic Hepatitis B
8-20-2010
|
Hepatitis
B Virus Infection Linked to Non-Hodgkin
Lymphoma in South Korean Study
8-02-2010
|
High
HBV Viral Load and HBeAg Positive Status Increase Risk
of Mother-to-child Hepatitis
B Transmission Despite Vaccine
7-16-2010
|
Is
Routine Hepatitis B Screening
Necessary Before Starting Cancer Chemotherapy?
7-13-2010
|
U.S.
Hepatitis B Prevalence in the HBV
Vaccine Era
7-02-2010
|
How
Long Do Chronic Hepatitis B Patients Need to be Treated
to Sustain HBeAg Seroconversion?
6-25-2010
|
CDC
Reports Increasing Incidence of Liver Cancer, Mostly Due
to Chronic Hepatitis B
and C
6-15-2010
|
Sex
Hormone Receptor May Explain Higher Risk of Hepatocellular
Carcinoma in Men
6-11-2010
|
HBeAg
Decrease during Treatment Predicts Sustained Response
to Pegylated Interferon
for Chronic Hepatitis B
6-08-2010
|
World
Hepatitis Alliance Releases Major
Report on Viral Hepatitis Policy at EASL Meeting
6-08-2010
|
Safety
Review Clears Continuation of Hepislav
Hepatitis B Vaccine
6-04-2010
|
Rifaximin
Reduces Encephalopathy Recurrence, Improves
Quality of Life in People with Liver Cirrhosis
6-04-2010
|
Advocates
Rally in San Francisco and Washington to Raise Awareness
and Demand Funding for Hepatitis
B and C
5-21-2010
|
GlaxoSmithKline
Halts Study of Eltrombopag (Promacta)
in People with Liver Disease Due to Blood Clot Risk
5-18-2010
|
Spontaneous
Undetectable Hepatitis B Virus
DNA Is Uncommon, especially without HBeAg Clearance
5-14-2010
|
Measurable
Neurocognitive Impairment Signals Hepatic Encephalopathy
in People with Liver Cirrhosis
5-11-2010
|
San
Francisco Launches Hepatitis
B Campaign to Raise Awareness in Asian Community
5-7-2010
|
Longer
Treatment with Pegylated Interferon
Works Better for Hepatitis B Genotype D
5-7-2010
|
Tenofovir
(Viread) Effective for Treatment of Chronic
Hepatitis B Patients with Suboptimal Response to Adefovir
(Hepsera)
5-7-2010
|
HBV
DNA and HBsAg Levels Predict Likelihood of Sustained Response
to Pegylated Interferon
for Hepatitis B
4-27-2010
|
MARS
and Prometheus Artificial Liver Devices Offer
Some Benefits for Patients with Liver Failure, but Did
Not Improve Survival
4-27-2010
|
Tenofovir
(Viread) Demonstrates High Barrier to Resistance
over 3 Years in Chronic Hepatitis B Patients
4-24-2010
|
World
Hepatitis Alliance Releases Major Report on Viral Hepatitis
Policy at EASL Meeting
4-20-2010
|
Tenofovir/emtricitabine
(Truvada) Prevents Hepatitis B Recurrence after
Liver Transplantation in Patients with Mild Kidney Impairment
4-20-2010
|
EASL
International Liver Congress Presents
New Data on Hepatitis B and C Pathogenesis
and Treatment
4-20-2010
|
Many
U.S. Babies Do Not Receive
Recommended Therapy to Prevent Hepatitis B Infection
4-16-2010 |
Traditional
Chinese Medicine May Perform Better than Interferon
or Lamivudine for Chronic Hepatitis B
4-6-2010
|
Entecavir
(Baraclude) Works Well in Patients With Adefovir-resistant
Hepatitis B, but Lamivudine Resistance Compromises Efficacy
4-6-2010
|
Entecavir
(Baraclude) Works Well in Patients With Adefovir-resistant
Hepatitis B, but Lamivudine Resistance Compromises Efficacy
4-2-2010
|
Investigational
Hepatitis B Vaccine Hepislav
Shows Favorable Safety Profile without Elevated Risk of
Autoimmunity
3-30-2010
|
Experimental
Hepatitis B Drug LB80380 Appears Safe and Effective
for Patients with Lamivudine-resistant HBV
3-26-2010
|
Antibiotic
Rifaximin Maintains Remission of Hepatic Encephalopathy
in People with Advanced Liver Disease
3-26-2010
|
National
Viral Hepatitis Roundtable Warns of Risks of Federal
Under-funding of Hepatitis B and C
3-23-2010
|
Adding
Adefovir (Hepsera)
to Lamivudine (Epivir-HBV)
Extends Biochemical Response, But May Cause Kidney Problems
3-19-2010
|
"Review
of Reviews" Examines Evidence for Effectiveness
of Needle Exchange Programs
3-19-2010
|
Boys
with Chronic Hepatitis B May Experience HBeAg
Seroconversion and Reduced HBV Viral Load at Puberty
3-9-2010
|
Executive
Summary Now Available from Hepatitis B and
C National Expert Policy Forum
2-19-2010
|
HBV
DNA Not Detected in Semen of Men with Chronic Hepatitis
B Successfully Treated with Nucleotide
Analogs
2-19-2010
|
Age
at Time of HBeAg Seroconversion Predicts Chronic
Hepatitis B Prognosis
2-19-2010
|
Hepatitis
B Surface Antigen Loss during Treatment with Entecavir
(Baraclude) or Lamivudine (Epivir-HBV)
2-12-2010
|
Entecavir
(Baraclude) Improves Liver Function in Chronic
Hepatitis B Patients with Decompensated Cirrhosis
2-05-2010
|
Perinatal
HBV Transmission May Occur Despite Newborn
Vaccination and Immune Globulin
2-05-2010
|
Long-term
Entecavir (Baraclude)
Produces Sustained Viral Suppression with Little Resistance
in HBeAg Positive Chronic Hepatitis B Patients
1-26-2010
|
Clinical
Course of Chronic Hepatitis B
in Children
1-22-2010
|
Chronic
Hepatitis B Patients with Liver
Cirrhosis Are at Risk for Lactic Acidosis after
Starting Entecavir (Baraclude)
1-22-2010
|
Chronic
Hepatitis B Patients with Liver Cirrhosis Are at Risk
for Lactic Acidosis after Starting Entecavir
(Baraclude)
1-19-2010
|
Tenofovir
(Viread) Produces Long-term Response in Chronic
Hepatitis B Patients with Prior Treatment Failure
1-15-2010
|
New
Institute of Medicine Report Outlines National Strategy
for Prevention and Control of
Hepatitis B and C
1-12-2010
|
Factors
that Predict Response to Pegylated
Interferon in HBeAg Positive Chronic Hepatitis
B Patients
1-08-2010
|
Patients
with HBV/HCV Coinfection May Experience HBV
Relapse after Sustained HCV Suppression
12-15-2009
|
Fewer
Viral Hepatitis Patients with End-stage Liver Disease
Are Awaiting Liver Transplants,
Likely Due to Effective Hepatitis B Treatment
12-11-2009
|
New
Study to Test Interleukin 7
in Combination with Antiviral Therapy and Vaccine for
Chronic Hepatitis B
12-11-2009
|
Tenofovir
(Viread) Produces Good HBV Suppression in Chronic
Hepatitis B Patients with Resistance to Adefovir
(Hepsera)
11-24-2009
|
Long-term
Data Show Telbivudine (Tyzeka)
Suppresses HBV Viral Load and Leads to HBeAg Clearance
in Chronic Hepatitis B Patients
11-24-2009
|
Review
Finds Pegylated Interferon
Is More Effective than Lamivudine for Chronic Hepatitis
B, but Study Shows Little Activity against HBV Genotype
D
11-17-2009
|
Early
HBsAg Decline Predicts Sustained Response to Pegylated
Interferon; Extended Treatment Can Improve
Outcomes
11-17-2009
|
Entecavir
(Baraclude) and Tenofovir (Viread) Rescue Therapy
for Chronic Hepatitis B Patients with Advanced Fibrosis
and Prior Treatment Failure
11-13-2009
|
High
HBV Viral Load and Being HBeAg Positive Are Associated
with Decreased Life Expectancy
for People with Hepatitis B
11-3-2009
|
Tenofovir
(Viread) Regimens Are Effective and Well-tolerated
in Chronic Hepatitis B Patients with Decompensated Liver
Disease
11-10-2009
|
Long-term
Studies Show Tenofovir (Viread)
Safety and Efficacy Is Sustained at 3 Years in HBeAg Positive
and Negative Hepatitis B Patients
11-3-2009
|
Entecavir
(Baraclude) Demonstrates Greater Antiviral
Activity than Adefovir (Hepsera)
in Hepatitis B Patients with Decompensated Liver Disease
11-3-2009
|
AASLD
Liver Meeting Starts
Today in Boston
10-30-2009
|
Hepatitis
B Virus Genotypes E, F, G, and H Appear Responsive to
Treatment with Interferon Alpha
10-13-2009
|
Most
Patients with Low Baseline HBV Viral Load Can Safely Discontinue
Lamivudine (Epivir-HBV)
after Achieving Virological Suppression
10-09-2009
|
Widespread
Hepatitis B Vaccination
Has Dramatically Reduced Rate of Liver Cancer among Children
and Young Adults in Taiwan
9-29-2009
|
AASLD
Issues Updated Practice Guidelines for Management of Chronic
Hepatitis B
9-22-2009
|
Sustained
Response in HBeAg Negative Chronic Hepatitis B Patients
3 Years After Treatment with
Pegasys
8-18-2009
|
FDA
Changes Regulations for Expanded
Access to Investigational Drugs
8-14-2009 |
Predictors
of Good Response to Telbivudine
(Tyzeka) for Chronic Hepatitis B
8-4-2009
|
Vertex
Aims to Receive $250 Million in Milestone Payments for
Anti-HCV Drug Telaprevir
after Approval in Europe
7-14-2009
|
CDC
Researchers Release Latest Hepatitis
A, B, and C Statistics
6-23-2009
|
Many
People with Chronic Hepatitis
B and C Do Not Receive Appropriate Treatment
6-16-2009
|
High
HBV DNA Level Is the Strongest Predictor of
Elevated ALT
6-9-2009
|
Should
Entecavir (Baraclude)
and Tenofovir (Viread)
Be First-line Treatment for Chronic Hepatitis B?
6-5-2009 |
